Dr. Lal Path Labs Ltd. Total Liabilities
Dr. Lal Path Labs Ltd. total liabilities. Based on the latest financial reports, Dr. Lal Path Labs Ltd. (LALPATHLAB) has total liabilities worth Rs6.05 Billion INR (≈ $65.40 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check LALPATHLAB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Dr. Lal Path Labs Ltd. (2011–2026)
Total liabilities of Dr. Lal Path Labs Ltd. from 2011 to 2026. This chart illustrates how Dr. Lal Path Labs Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore Dr. Lal Path Labs Ltd. long-term investment allocation to see how much of total assets are deployed in long-term investments.
Dr. Lal Path Labs Ltd. Competitors by Total Liabilities
The table below lists competitors of Dr. Lal Path Labs Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Minth Group Limited
F:M3I
|
Germany | €17.89 Billion |
|
Hunan Valin Steel Co Ltd
SHE:000932
|
China | CN¥85.27 Billion |
|
Atmus Filtration Technologies Inc.
NYSE:ATMU
|
USA | $1.44 Billion |
|
Life360, Inc. Common Stock
NASDAQ:LIF
|
USA | $438.49 Million |
|
Caihong Display Devices Co Ltd
SHG:600707
|
China | CN¥16.07 Billion |
|
Astor Enerji AS
IS:ASTOR
|
Turkey | TL17.40 Billion |
|
Cofinimmo SA
BR:COFB
|
Belgium | €2.88 Billion |
|
Anxin Trust Co Ltd
SHG:600816
|
China | CN¥10.45 Billion |
Liability Composition Analysis (2011–2026)
This chart breaks down Dr. Lal Path Labs Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Dr. Lal Path Labs Ltd. asset portfolio.
Liquidity & Leverage Metrics
Dr. Lal Path Labs Ltd. Total Liabilities Ratios Explained
Dr. Lal Path Labs Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dr. Lal Path Labs Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dr. Lal Path Labs Ltd. (2011–2026)
The table below shows the annual total liabilities of Dr. Lal Path Labs Ltd. from 2011 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs6.05 Billion ≈ $65.40 Million |
+18.50% |
| 2025-03-31 | Rs5.10 Billion ≈ $55.19 Million |
-10.57% |
| 2024-03-31 | Rs5.71 Billion ≈ $61.71 Million |
-16.82% |
| 2023-03-31 | Rs6.86 Billion ≈ $74.19 Million |
-15.28% |
| 2022-03-31 | Rs8.10 Billion ≈ $87.56 Million |
+110.14% |
| 2021-03-31 | Rs3.85 Billion ≈ $41.67 Million |
+20.31% |
| 2020-03-31 | Rs3.20 Billion ≈ $34.64 Million |
+129.56% |
| 2019-03-31 | Rs1.40 Billion ≈ $15.09 Million |
+12.60% |
| 2018-03-31 | Rs1.24 Billion ≈ $13.40 Million |
+21.50% |
| 2017-03-31 | Rs1.02 Billion ≈ $11.03 Million |
-11.88% |
| 2016-03-31 | Rs1.16 Billion ≈ $12.52 Million |
-12.29% |
| 2015-03-31 | Rs1.32 Billion ≈ $14.27 Million |
+11.63% |
| 2014-03-31 | Rs1.18 Billion ≈ $12.78 Million |
+12.19% |
| 2013-03-31 | Rs1.05 Billion ≈ $11.39 Million |
+75.66% |
| 2012-03-31 | Rs599.73 Million ≈ $6.49 Million |
-21.25% |
| 2011-03-31 | Rs761.59 Million ≈ $8.24 Million |
-- |
About Dr. Lal Path Labs Ltd.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomi… Read more